Picture
Dr.Shruti Bhat, Star formulator and Ace leader within pharmaceutical R&D, a specialist with hiTech formulations and quality-by-design.  Shruti brings to you some highlights from current pharma and clinical research news, views and data.
 
Large Drugmakers Placing New Emphasis On Targeted Cancer Treatments.
Increasingly, large pharmaceutical companies are restructuring their business models so that they can collaborate with small biotech firms to develop medications which target small groups, rather than large populations...
http://www.ft.com/cms/s/2/72803d54-9046-11df-ad26-00144feab49a,dwp_uuid=e8477cc4-c820-11db-b0dc-000b5df10621.html  

Experts Warn Absence Of Clinical Trials For Biosimilar Drugs Could Hurt Safety, Effectiveness.
Medical experts warned that the absence of mandatory clinical trials for biosimilar drugs could compromise their safety and effectiveness...
http://thehill.com/blogs/healthwatch/health-reform-implementation/109647-experts-concerned-about-lack-of-clinical-trials-for-biosimilar-drugs

Number Of HIV-Positive Patients Receiving Antiretroviral Drugs Increased By More Than A Quarter In 2009.
The number of HIV-positive people receiving antiretroviral drugs for their infections jumped by more than a quarter in 2009, growing from four million ...
http://www.latimes.com/news/health/boostershots/la-heb-aids-treatment-20100719,0,3111390.story

Bosentan May Not Improve Exercise Capacity In Patients With Systemic Sclerosis.
"Treatment with the endothelin receptor antagonist bosentan (Tracleer) failed to improve exercise capacity in patients with systemic ...
http://www.medpagetoday.com/Rheumatology/GeneralRheumatology/21082

Clinical Trials To Continue For Potential Hemophilia Drug.
"Biogen Idec Inc. and Swedish Orphan Biovitrum stated they will continue clinical testing of a potential hemophilia drug based ...
http://www.businessweek.com/ap/financialnews/D9GRJQP00.htm

Vaccine May Help Shrink The Most Deadly Cancers.
"An injection to help kill off the most deadly cancers...has been created by scientists" in the UK. The "Middlesex University vaccine capitalizes on the finding that ...
http://www.dailymail.co.uk/health/article-1293927/Jab-halt-deadly-forms-cancer.html

More updates athttp://www.pharm-education.com/2010/07/vaccine-may-help-shrink-most-deadly.html  

Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Http://www.drshrutibhat.comExpert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.
YouTube Channel : Http://www.youtube.com/user/ShrutiBhat10Do you have questions for the author? 

 


Comments

Nayan

Wed, 02 Mar 2011 21:14:33

Me and my colleagues authored one of India's most extensive reports on Biosimilars. Drop me a mail if you are interested in a copy. My email is ntaluk@gmail.com.

Some of the topics we included are:

- Market Trends
- Growth Drivers
- Regulatory Bodies and Framework
- Major Players.
-Etc.
We interviewed over 200 individuals and firms to collect the data in what we believe is one of the most detailed study on the subject in India.

Nayan
ntaluk@gmail.com

 



Leave a Reply